Simplex Trading’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,100
Closed -$399K 9593
2025
Q4
$399K Buy
4,100
+2,400
+141% +$206K ﹤0.01% 3522
2025
Q3
$120K Buy
+1,700
New +$113K ﹤0.01% 5530
2025
Q2
Sell
-2,300
Closed -$120K 9171
2025
Q1
$120K Hold
2,300
﹤0.01% 4877
2024
Q4
$126K Buy
+2,300
New +$121K ﹤0.01% 4960
2024
Q2
Sell
-600
Closed -$26K 9281
2024
Q1
$26K Hold
600
﹤0.01% 6874
2023
Q4
$28K Buy
+600
New +$25.2K ﹤0.01% 6624

Other funds holding IRMD

Simplex Trading's IRMD Position: Q1 2026 in Review

Simplex Trading sold out of iRadimed (IRMD) in Q1 2026, closing a stake of 32 shares — an estimated $3.11K sold.

Simplex Trading first reported a position in IRMD in Q3 2023 and held it in 6 quarters. The position peaked at $47K in Q1 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Simplex Trading reported no remaining iRadimed position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 32 iRadimed shares in Q1 2026, an estimated $3.11K.
  • Simplex Trading first reported a position in iRadimed in Q3 2023 and held it in 6 quarters.
  • Simplex Trading's iRadimed position peaked at $47K in Q1 2025.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.